These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9699049)

  • 41. Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: Incremental value of dynamic gadolinium-enhancement.
    Qayyum A; Thoeni RF; Coakley FV; Lu Y; Guay JP; Ferrell LD
    J Magn Reson Imaging; 2006 Jan; 23(1):17-22. PubMed ID: 16315209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver.
    Rode A; Bancel B; Douek P; Chevallier M; Vilgrain V; Picaud G; Henry L; Berger F; Bizollon T; Gaudin JL; Ducerf C
    J Comput Assist Tomogr; 2001; 25(3):327-36. PubMed ID: 11351179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
    Kobayashi S; Matsui O; Kamura T; Yamamoto S; Yoneda N; Gabata T; Terayama N; Sanada J
    J Comput Assist Tomogr; 2007; 31(4):557-63. PubMed ID: 17882031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The magnetic resonance of small hepatocarcinoma. A comparison with echography, computed tomography, digital angiography and computed tomography with lipiodol].
    De Santis M; Cristani A; Cioni G; Casolo A; Canossi G; Ventura E; Romagnoli R
    Radiol Med; 1992 Nov; 84(5):587-95. PubMed ID: 1335589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatocellular carcinoma in noncirrhotic patients. A laparoscopic study of 92 cases in Taiwan.
    Lin DY; Liaw YF; Chu CM; Chang-Chien CS; Wu CS; Chen PC; Sheen IS
    Cancer; 1984 Oct; 54(7):1466-8. PubMed ID: 6205744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
    Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The magnetic resonance and histological correlations in hepatocellular carcinoma].
    Bartolozzi C; Lencioni R; Caramella D; Paolicchi A; Russo R; Romani R
    Radiol Med; 1994; 87(1-2):90-5. PubMed ID: 8128039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging of hepatocellular carcinoma: a practical approach.
    Coakley FV; Schwartz LH
    Semin Oncol; 2001 Oct; 28(5):460-73. PubMed ID: 11685739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic evaluation of hepatocellular carcinoma in a cirrhotic liver.
    Gogel BM; Goldstein RM; Kuhn JA; McCarty TM; Donahoe A; Glastad K
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 3):15-20. PubMed ID: 10887647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pitfalls in the imaging diagnosis of hepatocellular nodules in the cirrhotic and noncirrhotic liver.
    Yoshimitsu K; Irie H; Aibe H; Tajima T; Nishie A; Asayama Y; Matake K; Nakayamka T; Kakihara D; Honda H
    Intervirology; 2004; 47(3-5):238-51. PubMed ID: 15383733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD; Kizziah MK; Rissing MS
    J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging.
    Lencioni R; Mascalchi M; Caramella D; Bartolozzi C
    Abdom Imaging; 1996; 21(1):41-8. PubMed ID: 8672971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.
    Trevisani F; D'Intino PE; Caraceni P; Pizzo M; Stefanini GF; Mazziotti A; Grazi GL; Gozzetti G; Gasbarrini G; Bernardi M
    Cancer; 1995 May; 75(9):2220-32. PubMed ID: 7536121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
    von Delius S; Lersch C; Schulte-Frohlinde E; Fend F; Dobritz M; Schmid RM; Eckel F
    Z Gastroenterol; 2006 Jan; 44(1):39-42. PubMed ID: 16397838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of hepatectomy for noncirrhotic hepatocellular carcinoma: a systematic review.
    Zhou Y; Lei X; Wu L; Wu X; Xu D; Li B
    Surg Oncol; 2014 Dec; 23(4):236-42. PubMed ID: 25465529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T; Baron RL; Federle MP; Peterson MS; Oliver JH; Davis PL; Confer SR
    Radiology; 1996 Feb; 198(2):567-72. PubMed ID: 8596867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.
    Li RK; Palmer SL; Zeng MS; Qiang JW; Chen F; Rao SX; Chen LL; Dai YM
    PLoS One; 2015; 10(11):e0142882. PubMed ID: 26605946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.